Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

NATEGLINIDE 120 MG TABLET

nateglinide
$0.2510per EA

Strength

120 mg/1

Manufacturer

Strides Pharma Inc.

NDC

64380016802

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

NATEGLINIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA077463

On Market Since

5/9/2022

Pharmacological Classes

Glinide
Potassium Channel Antagonists

Price History

1W

0.0%

1M

+0.6%

3M

-1.9%

6M

-1.2%

1Y

-10.5%

3Y

-10.3%

5Y

N/A

All

-15.9%

Generic Alternatives

1 alternative • Same active ingredient

NATEGLINIDE 120 MG TABLET
Generic
60687068421•American Health Packaging
$0.2510

Related Drugs

Same classification

REPAGLINIDE 1 MG TABLET
Generic
33342024911•Macleods Pharmaceuticals Limited
$0.0811
per EA
REPAGLINIDE 1 MG TABLET
Generic
57237015801•Rising Pharma Holdings Inc.
$0.0811
per EA
REPAGLINIDE 1 MG TABLET
Generic
60687056021•American Health Packaging
$0.0811
per EA
REPAGLINIDE 1 MG TABLET
Generic
62135094790•Chartwell RX LLC
$0.0811
per EA
REPAGLINIDE 1 MG TABLET
Generic
65862067101•Aurobindo Pharma Limited
$0.0811
per EA
REPAGLINIDE 1 MG TABLET
Generic
72603081101•NorthStar Rx LLC
$0.0811
per EA
REPAGLINIDE 0.5 MG TABLET
Generic
33342024811•Macleods Pharmaceuticals Limited
$0.0812
per EA
REPAGLINIDE 0.5 MG TABLET
Generic
57237015701•Rising Pharma Holdings Inc.
$0.0812
per EA
REPAGLINIDE 0.5 MG TABLET
Generic
62135094690•Chartwell RX LLC
$0.0812
per EA
REPAGLINIDE 0.5 MG TABLET
Generic
65862067001•Aurobindo Pharma Limited
$0.0812
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy